Colfax Announces Full Redemption of 6.000% Senior Notes due 2024 and $100 Million Partial Redemption of 6.375% Senior Notes due 2026
Colfax Corporation (NYSE: CFX) announced its intent to redeem $600 million of its 6.000% Senior Notes due 2024 and $100 million of its 6.375% Senior Notes due 2026 on April 24, 2021. The 2024 Notes will be redeemed at 103% of their principal value, while the 2026 Notes will be redeemed at 106.375% plus accrued interest. Following the redemption, interest on these notes will cease. Colfax has directed Wilmington Trust to inform registered holders about the redemption, and payment will be made through the paying agent.
- The redemption of $600 million in Senior Notes indicates strong cash management and liquidity.
- The specific redemption prices (103% for 2024 Notes and 106.375% for 2026 Notes) show that Colfax is managing debt effectively.
- None.
Annapolis Junction, MD, March 25, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (“Colfax” or the “Company”) (NYSE: CFX), a leading diversified technology company, announced today that it has given notice of its intention to redeem
Colfax has instructed Wilmington Trust, National Association, as the trustee for the Notes, to distribute a notice of redemption to all registered holders of the Notes on March 25, 2021. Wilmington Trust, National Association is the paying agent for the Notes. Payment of the redemption price for the Notes will be made to the paying agent pursuant to the indenture. All redeemed notes must be surrendered to the paying agent to collect the redemption price.
This press release shall not constitute a notice of redemption nor does it constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
ABOUT COLFAX CORPORATION
Colfax Corporation is a leading diversified technology company that provides orthopedic and fabrication technology products and services to customers around the world, principally under the DJO and ESAB brands. Colfax believes that its brands are among the most highly recognized in each of the markets that it serves. The Company uses its Colfax Business System (“CBS”), a comprehensive set of tools, processes and values, to create superior value for customers, shareholders and associates. Colfax’s common stock is traded on the NYSE under the ticker “CFX.”
This press release contains forward-looking statements, including forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are based on Colfax’s current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause Colfax’s results to differ materially from current expectations include, but are not limited to, risks related to the impact of the COVID-19 global pandemic, including actions by governments, businesses and individuals in response to the situation, such as the scope and duration of the outbreak, the nature and effectiveness of government actions and restrictive measures implemented in response, material delays and cancellations of medical procedures, supply chain disruptions, the impact on creditworthiness and financial viability of customers, and other impacts on Colfax’s business and ability to execute business continuity plans, and the other factors detailed in Colfax’s reports filed with the SEC, including its most recent Annual Report on Form 10-K for the year ended December 31, 2020 under the caption “Risk Factors,” as well as the other risks discussed in Colfax’s filings with the SEC. In addition, these statements are based on assumptions that are subject to change. This press release speaks only as of the date hereof. Colfax disclaims any duty to update the information herein.
Contact:
Mike Macek
Vice President, Finance
Colfax Corporation
+1-302-252-9129
investorrelations@colfaxcorp.com
FAQ
What is Colfax Corporation's recent announcement regarding its senior notes?
What are the redemption prices for Colfax's senior notes?
When will Colfax redeem its senior notes?